[go: up one dir, main page]

MX2014003770A - Tetrahidrato de la sal de l-arginina del acido s-(-)-9-fluoro-6,7-dihidro-8-(4-hidroxipiperidin-1-il)-5-metil-1- oxo-1h,5h-benzo[i,j] quinolizin-2-carboxilico puro, y un proceso para su preparacion. - Google Patents

Tetrahidrato de la sal de l-arginina del acido s-(-)-9-fluoro-6,7-dihidro-8-(4-hidroxipiperidin-1-il)-5-metil-1- oxo-1h,5h-benzo[i,j] quinolizin-2-carboxilico puro, y un proceso para su preparacion.

Info

Publication number
MX2014003770A
MX2014003770A MX2014003770A MX2014003770A MX2014003770A MX 2014003770 A MX2014003770 A MX 2014003770A MX 2014003770 A MX2014003770 A MX 2014003770A MX 2014003770 A MX2014003770 A MX 2014003770A MX 2014003770 A MX2014003770 A MX 2014003770A
Authority
MX
Mexico
Prior art keywords
hydroxypiperidin
quinolizine
benzo
dihydro
oxo
Prior art date
Application number
MX2014003770A
Other languages
English (en)
Other versions
MX366887B (es
Inventor
Kiran Kumar Gangakhedkar
Aniruddha Varangaonkar
Furqan Mohammed Diwan
Ravindra Datatraya Yeole
Keshav Deo
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Publication of MX2014003770A publication Critical patent/MX2014003770A/es
Publication of MX366887B publication Critical patent/MX366887B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Se describe tetrahidrato de la sal de L-arginina del ácido S-(-)-9-fluoro-6,7-dihidro-8-(4-hidroxipiperidin-1-il) 5-metil-1-oxo-1H,5H-benzo[i,j] quinolizin-2-carboxílico puro y un proceso para su preparación.
MX2014003770A 2011-09-28 2012-01-06 Tetrahidrato de la sal de l-arginina del ácido s-(-)-9-fluoro-6,7-dihidro-8- (4-hidroxipiperidin-1-il) -5-metil-1-oxo-1h, 5h-benzo[i,j] quinolizin-2-carboxílico puro, y un proceso para su preparación. MX366887B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2740MU2011 2011-09-28
PCT/IB2012/050074 WO2013046061A1 (en) 2011-09-28 2012-01-06 Pures-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1h,-5h-benzo[i,j]quinolizine-2- carboxylic acid l-arginine salt tetrahydrate and a process for its preparation

Publications (2)

Publication Number Publication Date
MX2014003770A true MX2014003770A (es) 2014-04-30
MX366887B MX366887B (es) 2019-07-29

Family

ID=45498072

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014003770A MX366887B (es) 2011-09-28 2012-01-06 Tetrahidrato de la sal de l-arginina del ácido s-(-)-9-fluoro-6,7-dihidro-8- (4-hidroxipiperidin-1-il) -5-metil-1-oxo-1h, 5h-benzo[i,j] quinolizin-2-carboxílico puro, y un proceso para su preparación.

Country Status (12)

Country Link
US (1) US20140296280A1 (es)
EP (1) EP2776433A1 (es)
JP (1) JP6126102B2 (es)
KR (1) KR20140054307A (es)
CN (1) CN103842361A (es)
AU (1) AU2012313987B2 (es)
BR (1) BR112014006401A2 (es)
CA (1) CA2850159A1 (es)
MX (1) MX366887B (es)
RU (1) RU2594166C2 (es)
WO (1) WO2013046061A1 (es)
ZA (1) ZA201401262B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109089413A (zh) * 2017-04-14 2018-12-25 沃克哈特有限公司 抗菌组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000068229A2 (en) * 1999-05-07 2000-11-16 Wockhardt Limited (s)-benzoquinolizine carboxylic acids and their use as antibacterial agents
CA2403264A1 (en) * 2000-05-08 2001-11-15 Noel John De Souza Chiral fluoroquinolizinone arginine salt forms
US6664267B1 (en) * 2002-05-28 2003-12-16 Wockhardt Limited Crystalline fluoroquinolone arginine salt form
AU2003304460A1 (en) * 2003-09-04 2005-03-29 Wockhardt Limited Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate
CN101500564B (zh) * 2006-03-07 2012-07-25 沃克哈特有限公司 苯并喹嗪-2-羧酸的前药

Also Published As

Publication number Publication date
BR112014006401A2 (pt) 2017-03-28
MX366887B (es) 2019-07-29
US20140296280A1 (en) 2014-10-02
RU2014115989A (ru) 2015-11-10
WO2013046061A1 (en) 2013-04-04
CN103842361A (zh) 2014-06-04
NZ621358A (en) 2016-03-31
AU2012313987A1 (en) 2014-03-06
RU2594166C2 (ru) 2016-08-10
AU2012313987B2 (en) 2016-11-24
KR20140054307A (ko) 2014-05-08
CA2850159A1 (en) 2013-04-04
ZA201401262B (en) 2015-10-28
JP6126102B2 (ja) 2017-05-10
JP2014527998A (ja) 2014-10-23
EP2776433A1 (en) 2014-09-17

Similar Documents

Publication Publication Date Title
MY182428A (en) Crystalline forms of a prolyl hydroxylase inhibitor
PH12013500554A1 (en) Process for preparing pan-cdk inhibitors of the formula (i) and intermediates in the preparation
MX2013000009A (es) Procedimiento de preparacion de la sal de l-arginina de perindoprilo.
HK1205095A1 (en) Methods and intermediates for preparing pharmaceutical agents
GB201107985D0 (en) Process
JO2930B1 (en) A new process for the synthesis of ivabradine and salts of addition with a pharmaceutically acceptable acid
MX2011012233A (es) Soluciones de retinoide topicas.
EP2663546A1 (fr) Procede de production de composes nitrile-acide gras
JO2854B1 (en) A new method for the synthesis of anfabradine and its added salts with acid is pharmaceutically acceptable.
MY170662A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MX2014003770A (es) Tetrahidrato de la sal de l-arginina del acido s-(-)-9-fluoro-6,7-dihidro-8-(4-hidroxipiperidin-1-il)-5-metil-1- oxo-1h,5h-benzo[i,j] quinolizin-2-carboxilico puro, y un proceso para su preparacion.
TN2015000095A1 (en) Macrolide derivatives, preparation thereof and therapeutic use thereof
EP2681185B8 (de) Verfahren zur herstellung von aryl- und heteroarylessigsäure-derivaten
IN2014DE01203A (es)
MX2013002990A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
JO3083B1 (ar) عملية جديدة لتخليق إيفابرادين وأملاحه المضافة مع حمض مقبول صيدلانيا
EP2750706A4 (en) 2-HYDROXYHIPPURIC ACID ANALOGUES AND METHODS FOR THEIR SYNTHESIS AND USE
WO2014083572A8 (en) A process for the preparation of d-threo-ritalinic acid salts via novel salts of intermediate thereof
PL394460A1 (pl) Sposób plazmowej modyfikacji kwasu α-ketoglutarowego i soli kwasu α-ketoglutarowego
PL396871A1 (pl) Kwas naftaleno-1,4-difosfonowy, sposób wytwarzania kwasu naftaleno-1,4-difosfonowego i zastosowanie kwasu naftaleno-1,4-difosfonowego
TN2013000128A1 (en) Process for preparing pan-cdk inhibitors of the formula (1), and intermediates in the preparation
AU2011900159A0 (en) Process for capturing acid gases
MX345518B (es) Compuestos analgesicos, metodos, y formulaciones.
UA67859U (en) 3,4-dimethyl-1-ethylcyclohex-3-ene carboxylic acid
UA71417U (uk) КАЛІЙНА СІЛЬ 5,7-ДИМЕТИЛ-6-ФЕНІЛАЗО-3H-ТІАЗОЛО[4,5-b]ПІРИДИН-2-ОНУ, ЩО ПРОЯВЛЯЄ АНТИЕКСУДАТИВНУ ДІЮ

Legal Events

Date Code Title Description
FG Grant or registration